The Burden of High-Energy Musculoskeletal Trauma in High-Income Countries.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 26 7 2018
medline: 29 1 2021
entrez: 26 7 2018
Statut: ppublish

Résumé

Though declining in the recent decades, high-energy musculoskeletal trauma remains a major contributor to the burden of disease in high-income countries (HICs). However, due to limitations in the available body of the literature, evaluation of this burden is challenging. The purpose of this review is to assess: (1) the current epidemiologic data on the surgical burden of high-energy musculoskeletal trauma in HICs; (2) the current data on the economic impact of high-energy musculoskeletal trauma; and (3) potential strategies for addressing gaps in musculoskeletal trauma care for the future. In 2016, mortality from road traffic injuries (RTIs) between the ages of 15-49 was reported to be 9.5% (9.0-9.9) in high-income countries, accounting for approximately 255 million DALYs. While RTIs do not fully capture the extent of high-energy musculoskeletal trauma, as the most common mechanism, they serve as a useful indicator of the impact on the surgical and economic burden. In 2009, the global losses related to RTIs were estimated to be 518 billion USD, costing governments between 1 and 3% of their gross domestic product (GDP). In the last decade, both the total direct per-person healthcare cost and the incremental direct per-person costs for those with a musculoskeletal injury in the USA rose 75 and 58%, respectively. ADDRESSING THE GAPS: While its impact is large, research on musculoskeletal conditions, including high-energy trauma, is underfunded compared to other fields of medicine. An increased awareness among policy makers and healthcare professionals of the importance of care for the high-energy musculoskeletal trauma patient is critical. Full implementation of trauma systems is imperative, and metrics such as the ICD-DALY have the potential to allow for real-time evaluation of prevention and treatment programs aimed to reduce injury-related morbidity and mortality. The dearth in knowledge in optimal and cost-effective post-acute care for high-energy musculoskeletal trauma is a reason for concern, especially since almost half of the costs are attributed to this phase of care. Multidisciplinary rehabilitation teams as part of a musculoskeletal trauma system may be of interest to decrease further the long-term negative effects and the economic burden of high-energy musculoskeletal trauma.

Identifiants

pubmed: 30043200
doi: 10.1007/s00268-018-4742-3
pii: 10.1007/s00268-018-4742-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1033-1038

Références

J Orthop Trauma. 2003 Jan;17(1):38-47
pubmed: 12499966
J Occup Environ Med. 2017 Apr;59(4):402-411
pubmed: 28628049
Injury. 2018 Mar;49(3):549-555
pubmed: 29433800
Clin Exp Emerg Med. 2016 Dec 30;3(4):219-238
pubmed: 28168229
J Occup Rehabil. 2016 Sep;26(3):319-31
pubmed: 26687330
Med J Aust. 2017 Sep 18;207(6):244-249
pubmed: 28899316
Injury. 2017 Jul;48(7):1331-1338
pubmed: 28554665
World J Surg. 2012 May;36(5):959-63
pubmed: 22419411
Int J Prev Med. 2013 Dec;4(12):1442-50
pubmed: 24498501
Surg Clin North Am. 2017 Oct;97(5):1119-1131
pubmed: 28958361
J Surg Res. 2017 Dec;220:213-222
pubmed: 29180184
Spine (Phila Pa 1976). 1996 Feb 15;21(4):492-9
pubmed: 8658254
Clin Orthop Relat Res. 2008 Oct;466(10):2306-16
pubmed: 18679760
J Bone Joint Surg Br. 2006 Nov;88(11):1469-73
pubmed: 17075092
Acta Orthop. 2012 Jun;83(3):276-81
pubmed: 22401675
Scand J Trauma Resusc Emerg Med. 2012 Dec 21;20:85
pubmed: 23259662
J Trauma Acute Care Surg. 2013 Jun;74(6):1516-20
pubmed: 23694881
J Orthop Trauma. 2017 Apr;31 Suppl 1:S71-S77
pubmed: 28323806
J Bone Joint Surg Am. 2005 Aug;87(8):1801-9
pubmed: 16085622
Acta Orthop. 2008 Aug;79(4):526-33
pubmed: 18766487
Injury. 2017 Oct;48(10):2157-2161
pubmed: 28807429
PLoS One. 2012;7(8):e43367
pubmed: 22937040
Acta Orthop Scand. 1992 Jun;63(3):297-300
pubmed: 1609594
J Bone Joint Surg Br. 2005 Jul;87(7):969-73
pubmed: 15972913
J Bone Joint Surg Am. 2015 Feb 18;97(4):265-72
pubmed: 25695975
Injury. 2009 Mar;40(3):304-8
pubmed: 19171340
Trauma Surg Acute Care Open. 2017 Sep 11;2(1):e000102
pubmed: 29766100
Clin Orthop Relat Res. 1981 Mar-Apr;(155):43-7
pubmed: 7226629
J Trauma Acute Care Surg. 2017 Nov;83(5):917-925
pubmed: 28715361
Ann Emerg Med. 2003 Jun;41(6):798-9
pubmed: 12764333
Injury. 2018 Feb;49(2):208-212
pubmed: 29153449
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
Injury. 1996;27 Suppl 1:S-A13-20
pubmed: 8762338
J Bone Joint Surg Am. 2013 Mar 20;95(6):e321-7
pubmed: 23515993
Surgery. 2008 Aug;144(2):307-16
pubmed: 18656640
J Trauma. 2007 Nov;63(5):1066-73; discussion 1072-3
pubmed: 17993952
Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-317-W5-325
pubmed: 15983005
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
World Neurosurg. 2018 Feb;110:e427-e437
pubmed: 29138069

Auteurs

P Hoogervorst (P)

Department of Orthopaedic Surgery, Orthopaedic Trauma Institute, Institute of Global Orthopaedics and Traumatology, University of California, San Francisco, Zuckerberg San Francisco General Hospital, 2550 23rd St, San Francisco, CA, 94110, USA.

D W Shearer (DW)

Department of Orthopaedic Surgery, Orthopaedic Trauma Institute, Institute of Global Orthopaedics and Traumatology, University of California, San Francisco, Zuckerberg San Francisco General Hospital, 2550 23rd St, San Francisco, CA, 94110, USA.

T Miclau (T)

Department of Orthopaedic Surgery, Orthopaedic Trauma Institute, Institute of Global Orthopaedics and Traumatology, University of California, San Francisco, Zuckerberg San Francisco General Hospital, 2550 23rd St, San Francisco, CA, 94110, USA. Theodore.Miclau@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH